StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
7523.T$1625.00-0.30%
Fair $1625.00+0.0%

7523.T

Art Vivant Co., Ltd.

Consumer Cyclical / Personal ServicesTokyo

$1625.00

-5.00 (-0.30%)

Fairly Valued+0.0%Fair Value $1625.00Fund rank 23/100 · Data gapFallback financials|
SA 48/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $56.6M · quality 34.0/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

48/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 7523.TLocal privado en este navegador · Art Vivant Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$14.9B

P/E

8.8x

↓

EV/EBITDA

9.1x

↓

ROE

8.3%

↑

Gross Margin

66.8%

↑

Debt/Equity

0.77

↑
52-Week Range$1625
$1009$2170

TradingView lightweight chart

7523.T price, volumen y niveles de valoración

Último $1,636Periodo -70.0%
Fair value: $1,625

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+1.5%

FCF CAGR

—

FCF margin

17.9%

FCF / Net income

1.52x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $10.73B · net income $1.27B · FCF $1.92B

2022-FY → 2025-FY

Gross margin

66.8%+3.3% pts

Operating margin

19.7%-1.4% pts

Net margin

11.8%+0.6% pts

FCF margin

17.9%+21.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$10.73B$10.73B$11.01B$10.72B$10.25B
Net Income$1.27B$1.27B$1.77B$1.35B$1.15B
EBITDA$2.40B$2.40B$3.04B$2.04B$2.21B
EPS130.61130.61163.86123.83106.91
Gross Margin66.8%66.8%64.5%64.9%63.5%
Operating Margin19.7%19.7%21.5%21.0%21.1%
Net Margin11.8%11.8%16.1%12.6%11.2%
Balance Sheet
Debt/Equity0.770.770.660.650.55
Current Ratio1.781.78———
Cash Flow
Free Cash Flow$1.92B$1.92B$-587.9M$56.6M$-408.2M
Returns
ROE8.3%8.3%11.1%8.8%8.1%
Valuation
P/E8.788.786.514.905.28
EV/EBITDA9.069.065.685.444.53
P/B1.031.030.720.430.43
Growth & Yield
Revenue Growth-2.5%-2.5%2.6%4.6%—
EPS Growth-20.3%-20.3%32.3%15.8%—
Dividend Yield1.8%1.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

3.4%

fácil

EPS terminal req.

$144.19

Spread vs growth

-23.6%

5Y implied EPS CAGR

6.0%

razonable

EPS terminal req.

$174.47

Spread vs growth

-26.3%

10Y implied EPS CAGR

8.0%

razonable

EPS terminal req.

$280.99

Spread vs growth

-28.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +58.1%

Total return

+58.1%

Start / end P/E

6.4x → 12.5x

EPS bridge

163.86 → 130.61

Residual

-19.5%

EPS growth-20.3%
Multiple rerating+96.0%
Dividend+1.8%
Residual / FX / buybacks / cross-term-19.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.